The global paracetamol IV market size was USD 797.08 million in 2024, estimated at USD 823.78 million in 2025, and is expected to reach around USD 1,117.85 million by 2034, expanding at a CAGR of 3.4% ...

Among infants undergoing major surgery, postoperative use of intermittent intravenous paracetamol (acetaminophen) for the management of pain resulted in a lower cumulative morphine dose over 48 hours.

Introduction: There are recent observations on the haemodynamics of intravenous paracetamol (hypotension) in adult IC setting (1). We therefore evaluated the haemodynamics following iv paracetamol ...

Children are at risk for overdose from intravenous (IV) paracetamol, which often arises from a 10-fold calculation error or when oral and IV dosing are given together ...

Anhui Fubore Pharmaceutical And Chemical Co. Ltd., Anqiu Luan Pharmaceutical Co. Ltd., ATABAY KIMYA SANAYI TICARET AS, Biological E. Ltd., Cipla Inc., Granules India ...

Although opioids play a very important role in postoperative pain mediation and control, these drugs are associated with significant side effects. Relatively few data have been published on the opioid ...

VRL had filed the post-grant opposition against SCR Pharmatop’s intravenous paracetamol patent back in 2011 before Indian Patent Office on several grounds such as lack of novelty and inventive steps, ...

CHICAGO – Among infants undergoing major surgery, postoperative use of intermittent intravenous paracetamol (acetaminophen) for the management of pain resulted in a lower cumulative morphine dose over ...

(MENAFN- GlobeNewsWire - Nasdaq) The growing demand to treat average pain or fever by providing speedy pain or relief is driving the market growth. Intravenous usage of paracetamol is executed in ...

In a decision dated 4 th June, 2021, the Indian Patent Office decided in favour of Venus Remedies and upheld its decision for revocation of the Indian patent on the grounds that the process lacked any ...